Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1388-1393

  Gleason, Joseph M ^a   Slezak, Jeffrey M ^a   Jung, Howard ^a   Reynolds, Kristi ^a   Van Den Eeden, Stephen K ^b   Haque, Reina ^a   Quinn, Virginia P ^a   Loo, Ronald K ^a   Jacobsen, Steven J ^a  

^a LAMC ^*  (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

age factors; anti inflammatory agents, non steroidal; comorbidity; erectile dysfunction; penis

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; CELECOXIB; EXCEDRIN; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; ERECTILE DYSFUNCTION; ETHNICITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SMOKING HABIT;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 79952704350     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.11.092     Document Type: Article

References (15)

1. Prins J, Blanker MH, Bohnen AM et al: Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impotence Res 2002; 14: 422.
2. Lue TF: Erectile dysfunction. N Engl J Med 2000; 342: 1802.
3. Ponholzer A, Temmlb C, Mocka K et al: Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47: 80.
4. Final Report on the Aspirin Component of the Ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321: 129.
5. Inman BA, Sauver JL, Jacobson DJ et al: A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108.
6. Lue TF: Physiology of penile erection and pathophysiology of erectile dysfunction. In: Campbell- Walsh Urology, 9th ed. Edited by AJ Wein, LR Kavoussi, AC Novick et al. New York: Elsevier 2007; sect VI, chapt 21.
7. Blumentals WA, Gomez-Caminero A, Joo S et al: Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impotence Res 2004; 16: 350.
8. Shiri R, Koskimäki J, Häkkinen J et al: Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. J Urol 2006; 175: 1812.
9. Enger SM, Van Den Eeden SK, Sternfeld B et al: California Men's Health Study (CMHS): a multi-ethnic cohort in a managed care setting. BMC Public Health 2006; 6: 172.
10. Derby CA, Araujo AB, Johannes CB et al: Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impotence Res 2000; 12: 197.
11. O'Donnell AB, Araujo AB, Goldstein I et al: The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med 2005; 20: 515.
12. Smith JF, Caan BJ, Sternfeld B et al: Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med 2009; 6: 3433.
13. Melman A and Gingell JC: The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5.
14. McVary KT: Erectile dysfunction. N Engl J Med 2007; 357: 2472.
15. McKanna JA, Zhang MZ, Wang JL et al: Constitutive expression of cyclooxygenase-2 in rat vas deferens. Am J Physiol 1998; 275: 227.